Fitch Ratings November 24, 2020
Related Fitch Ratings Content: Fitch Ratings 2021 Outlook: U.S. Healthcare and Pharmaceuticals (Pre-Pandemic Trends Intact in a Recession-Resistant Sector)
Fitch Ratings- The sector Outlook for U.S. healthcare and pharmaceutical companies in 2021 is Stable, according to Fitch Ratings. The rating Outlook is also Stable.
The Stable sector Outlook for 2021 reflects an expectation that favorable pre-pandemic operating trends are largely intact for U.S. healthcare and pharmaceutical issuers. A solid demand Outlook remains supportive of credit profiles, but threats to profitability are expanding, including weaker pricing power in a recessionary environment. However, the industry has historically proven adept at defending profitability in the face of regulatory and macroeconomic headwinds, and we believe the recession-resistant nature of demand will help issuers maintain...
Today's Sponsors
Today's Sponsor